Anna M. Mc Laughlin
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Model-Based Analysis with Mechanistic Insights to CAR-T-Cell Therapy Kinetics: Case Study with Axicabtagene Ciloleucel and Brexucabtagene Autoleucel.
Journal: Clinical pharmacology and therapeutics
Published: March 02, 2026
Optimizing Clinical Study Designs for CAR-T Cell Therapy: Development of an Efficient Sampling Strategy Through Optimal Experimental Design.
Journal: CPT: pharmacometrics & systems pharmacology
Published: February 21, 2026
TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16).
Journal: Clinical pharmacokinetics
Published: June 15, 2025
TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16).
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 29, 2023
Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort.
Journal: Clinical pharmacology and therapeutics
Published: September 13, 2023
Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modeling.
Journal: CPT: pharmacometrics & systems pharmacology
Published: May 12, 2023
Letter to the editor: Quality criteria for computational models predicting individual outcomes in CAR-T cell therapy.
Journal: Journal for immunotherapy of cancer
Published: April 06, 2023
Development and validation of a bioanalytical method for the quantification of axitinib from plasma and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MS.
Journal: Journal of pharmaceutical and biomedical analysis
Published: July 11, 2022
Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol.
Journal: Cancers
Published: November 10, 2021
Cost-effectiveness of oral anticancer drugs and associated individualised dosing approaches in patients with cancer: protocol for a systematic review.
Journal: BMJ open
Published: August 18, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026